Drawing for COMPLETE POC

USPTO serial 86183730

COMPLETE POC

Reviewed by CopyMark Law Group

Reg. 4813714Status 710
Filing date
Status date
Registration date
Sep 15, 2015
Examiner
NEVILLE, BRIAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with COMPLETE POC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William M. Bryner

William M. Bryner Kilpatrick Townsend & Stockton LLP1100 Peachtree Street, Suite 2800Mailstop: IP Docketing - 22Atlanta, GA 30309

Goods and services

ClassDescriptionStatusFirst use
035Business management, business strategy, business consultancy and advisory services for the pharmaceutical, medical device, food and healthcare industries; market research, namely, collecting market trends data from providers and patients, data on health economic issues, and competitive intelligence data on the marketplace for pharmaceutical products and medical devices; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; administering customer service programs, namely, operating patient assistance programs for pharmaceutical products and medical devices, and providing access to advocacy groups and counseling for patients to promote patient satisfaction; information and advisory services relating to the foregoingSECTION 8 - CANCELLEDJan 1, 2014
042Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and bio chemicals; research and development of antibodies for in vitro and in vivo use; custom design and development of chemical reagents and biochemical assays; consulting services for others in the field of design, planning, and project management of scientific research, drug development, and clinical trials; medical and scientific research, namely, designing, organizing, conducting, and managing clinical trials for others; clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; scientific laboratory services; laboratory research services relating to pharmaceuticals, medical devices, biotechnology, bio chemicals, antibodies, molecules for drug development, bio marker analysis, pharmacology, toxicology, drug metabolism, pharmacokinetics, biology, immunochemistry, health vaccines, pathology, and isotope chemistry; operating and maintaining a bio repository for medical and scientific research purposes; scientific research and analysis in the fields of bio markers, genomics, proteomics, and genotyping; computer software design; development, updating and maintenance of software and databases; data mining; providing temporary use of on-line non-downloadable software for tracking, monitoring, analyzing, and reporting information and statistics in the fields of pharmaceutical and medical device development studies, clinical trials, patient reimbursement and insurance coverage, and biological research; food safety testing and consultation related thereto; scientific consulting and research services relating to food, food packaging, and nutritional chemistry; information and advisory services relating to the foregoingSECTION 8 - CANCELLEDJan 1, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 25, 2022C8..CANCELLED SEC. 8 (6-YR)—
Sep 15, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 20, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 15, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 8, 2015SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 7, 2015CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 11, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 10, 2015SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 10, 2015EX2GSOU EXTENSION 2 GRANTED—
Jul 9, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 7, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 9, 2015IUAFUSE AMENDMENT FILED—
Jun 9, 2015EXT2SOU EXTENSION 2 FILED—
Jun 9, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2015EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 6, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 4, 2014EX1GSOU EXTENSION 1 GRANTED—
Dec 4, 2014EXT1SOU EXTENSION 1 FILED—
Dec 4, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 15, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 15, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 13, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2014DOCKASSIGNED TO EXAMINER—
Feb 14, 2014AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Feb 14, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 7, 2014ALIEASSIGNED TO LIE—
Feb 7, 2014PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 7, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance